In vivo experiments further revealed that KHSRP silencing markedly increased the infiltration of CD4+, CD8+, Granzyme B+, IFN-γ+, and TNF-α+ cells within the tumor, suggesting that KHSRP could serve as a potential prognostic marker and therapeutic target for gastric cancer. Here, CD4 is linked to neoplasm.